Cargando…

Clonal dynamics in a composite chronic lymphocytic leukemia and hairy cell leukemia‐variant

Composite lymphoma is the rare simultaneous manifestation of two distinct lymphomas. Chronic lymphocytic leukemia (CLL) has a propensity for occurring in composite lymphomas, a phenomenon that remains to be elucidated. We applied cytogenetics, droplet digital polymerase chain reaction, and massively...

Descripción completa

Detalles Bibliográficos
Autores principales:	Locher, Maurus, Jukic, Emina, Bohn, Jan‐Paul, Untergasser, Gerold, Steurer, Michael, Cramer, Christian Andreas, Schwendinger, Simon, Vogi, Verena, Verdorfer, Irmgard, Witsch‐Baumgartner, Martina, Nachbaur, David, Gunsilius, Eberhard, Wolf, Dominik, Zschocke, Johannes, Steiner, Normann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2020
Materias:	Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984250/ https://www.ncbi.nlm.nih.gov/pubmed/33277788 http://dx.doi.org/10.1002/gcc.22925

Ejemplares similares

Amp(1q) and tetraploidy are commonly acquired chromosomal abnormalities in relapsed multiple myeloma
por: Locher, Maurus, et al.
Publicado: (2022)

The prognostic value of additional copies of 1q21 in multiple myeloma depends on the primary genetic event
por: Locher, Maurus, et al.
Publicado: (2020)

The Biology of Classic Hairy Cell Leukemia
por: Bohn, Jan-Paul, et al.
Publicado: (2021)

The FMS like Tyrosine Kinase 3 (FLT3) Is Overexpressed in a Subgroup of Multiple Myeloma Patients with Inferior Prognosis
por: Steiner, Normann, et al.
Publicado: (2020)

Vasohibin inhibits angiogenic sprouting in vitro and supports vascular maturation processes in vivo
por: Kern, Johann, et al.
Publicado: (2009)

Spliced XBP1 Levels Determine Sensitivity of Multiple Myeloma Cells to Proteasome Inhibitor Bortezomib Independent of the Unfolded Protein Response Mediator GRP78
por: Borjan, Bojana, et al.
Publicado: (2020)

Response
por: Vogi, Verena, et al.
Publicado: (2022)

Low‐dose vemurafenib in hairy cell leukemia patients with active infection
por: Bohn, Jan‐Paul, et al.
Publicado: (2019)

Long-term treatment of hairy cell leukemia with interferon-α: still a viable therapeutic option
por: Bohn, Jan-Paul, et al.
Publicado: (2016)

High levels of FLT3-ligand in bone marrow and peripheral blood of patients with advanced multiple myeloma
por: Steiner, Normann, et al.
Publicado: (2017)

Quantification of circulating endothelial and progenitor cells: comparison of quantitative PCR and four-channel flow cytometry
por: Steurer, Michael, et al.
Publicado: (2008)

Clonal hematopoiesis in patients with Covid‐19 is stable and not linked to an aggravated clinical course
por: Petzer, Verena, et al.
Publicado: (2021)

The Aplidin analogs PM01215 and PM02781 inhibit angiogenesis in vitro and in vivo
por: Borjan, Bojana, et al.
Publicado: (2015)

Expression and release of glucose-regulated protein-78 (GRP78) in multiple myeloma
por: Steiner, Normann, et al.
Publicado: (2017)

Clonal Hematopoiesis of Indeterminate Potential and Diabetic Kidney Disease: A Nested Case-Control Study
por: Denicolò, Sara, et al.
Publicado: (2022)

Genomics of Hairy Cell Leukemia
por: Tiacci, Enrico, et al.
Publicado: (2017)

Treatment of Classic Hairy Cell Leukemia: Targeting Minimal Residual Disease beyond Cladribine
por: Bohn, Jan-Paul, et al.
Publicado: (2022)

Immunophenotypic Analysis of Hairy Cell Leukemia (HCL) and Hairy Cell Leukemia-like (HCL-like) Disorders
por: Maitre, Elsa, et al.
Publicado: (2022)

Deciphering Genetic Alterations of Hairy Cell Leukemia and Hairy Cell Leukemia-like Disorders in 98 Patients
por: Maitre, Elsa, et al.
Publicado: (2022)

Simultaneous Presentation of Hairy Cell Leukemia and Acute Lymphoblastic Leukemia
por: Li, Mingyong, et al.
Publicado: (2021)

BRAF Mutation in Hairy Cell Leukemia
por: Ahmadzadeh, Ahmad, et al.
Publicado: (2014)

Hairy cell leukemia – immunotargets and therapies
por: Basheer, Faisal, et al.
Publicado: (2014)

Skeletal involvement of hairy cell leukemia
por: Durot, Eric, et al.
Publicado: (2018)

Time to Cure Hairy Cell Leukemia
por: Levy, Ilana, et al.
Publicado: (2017)

An Unusual Presentation of Hairy Cell Leukemia
por: Gajendra, Smeeta, et al.
Publicado: (2019)

Variant form of hairy cell leukemia
por: Wiber, Margaux, et al.
Publicado: (2019)

Skin changes in hairy cell leukemia
por: Robak, Ewa, et al.
Publicado: (2020)

Adenoviral-Mediated Endothelial Precursor Cell Delivery of Soluble CD115 Suppresses Human Prostate Cancer Xenograft Growth in Mice
por: Lucas, Trevor, et al.
Publicado: (2009)

Marine compounds inhibit growth of multiple myeloma in vitro and in vivo
por: Steiner, Normann, et al.
Publicado: (2015)

The genomic landscape and clonal evolutionary trajectory of classical hairy cell leukemia
por: Moreno Rueda, Luz Yurany, et al.
Publicado: (2023)

Changing Landscape in the Treatment of Adult Acute Lymphoblastic Leukemia (ALL)
por: Künz, Tina, et al.
Publicado: (2022)

Laparoscopic Splenectomy for Hairy Cell Leukemia in Pregnancy
por: Adeniji, Beni Adegoke, et al.
Publicado: (2010)

A Unique Hairy Cell Leukemia Variant
por: Jian, Charles, et al.
Publicado: (2016)

Hairy Cell Leukemia Masquerading as Pancytopenia in Pregnancy
por: Shackleton, Louisa, et al.
Publicado: (2019)

Development of Recombinant Immunotoxins for Hairy Cell Leukemia
por: Kreitman, Robert J., et al.
Publicado: (2020)

Disseminated Histoplasmosis with Concurrent Hairy Cell Leukemia
por: Khan, Abdul Moiz, et al.
Publicado: (2020)

Patients with relapsed/refractory hairy‐cell leukemia
por: Paillassa, Jérôme, et al.
Publicado: (2021)

Hairy Cell Leukemia: Where Are We in 2023?
por: Mendez-Hernandez, Andres, et al.
Publicado: (2023)

Hairy cell leukemia with isolated bone lesions
por: Cailly, Laura, et al.
Publicado: (2023)

Biomarkers of evasive resistance predict disease progression in cancer patients treated with antiangiogenic therapies
por: Pircher, Andreas, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_rv2b0ub90njuo9slj628k045vd